THE SCID MOUSE MUTANT - DEFINITION AND POTENTIAL USE AS A MODEL FOR IMMUNE AND HEMATOLOGICAL DISORDERS

Citation
V. Leblond et al., THE SCID MOUSE MUTANT - DEFINITION AND POTENTIAL USE AS A MODEL FOR IMMUNE AND HEMATOLOGICAL DISORDERS, HEM CELL TH, 39(5), 1997, pp. 213-221
Citations number
102
Categorie Soggetti
Hematology
Journal title
HEMATOLOGY AND CELL THERAPY
ISSN journal
12693286 → ACNP
Volume
39
Issue
5
Year of publication
1997
Pages
213 - 221
Database
ISI
SICI code
1269-3286(1997)39:5<213:TSMM-D>2.0.ZU;2-I
Abstract
Mice homozygous for a SCID mutation (SCID mice) are severely deficient in T and B lymphocytes. The absence of effector T and B cells has enc ouraged investigators to attempt engraftement of SCID mice with human fetal tissues, mature lymphocytes, hematopoietic progenitors and tumor s. SCID mice can be reconstituted with human lymphocytes and are of in terest for studying normal and abnormal lymphocyte develop ment and fu nction. SCID mice are also providing an in vivo model of infectious di seases. In addition, SCID mice readily support normal and pathologic h uman hematopoiesis differentiation and is useful for testing innovativ e hematological disease therapy. SCID mice with a fully functionnal hu man immune or hematopoietic system therefore seem to be extremely valu able for biomedical research.